Loading
NYSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$10.78
+$0.13 · +1.22%
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Previous close
$10.78
+$0.13 · +1.22%
Pre-market
$10.72
−$0.06 · -0.56%
Oct 8, 7:12 AM ET
Regular session · ET · Market data may be delayed.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $10.78
52-week range
Current $10.78
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
61
Undervalued
Sentiment
53
Mixed
Risk
67
High Risk
Momentum
57
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $10.78
52-week range
Current $10.78
| Metric (USD) | FY2025 |
|---|---|
| Revenue | 1.18B USD |
| Cost of goods sold | 470.01M USD |
| Gross profit | 711.17M USD |
| Selling, general, and administrative | 445.21M USD |
| Operating expenses | 562.85M USD |
| Interest income | 14.52M USD |
| Interest expense | 63.45M USD |
| Depreciation and amortization | 173.4M USD |
| Operating income | 148.32M USD |
| Net income | −116.38M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$15.00
39.15% upsideFunds reporting this stock among their holdings, ordered by reported position size.
AdvisorShares Pure US Cannabis ETFMSOS275.42M32.81%839.37M USD0.81%$4.47+0.45%
Amplify Seymour Cannabis ETFCNBS10.27M14.66%70.24M USD1.09%$25.69-0.09%
Schwab U.S. Small-Cap ETFSCHA9.42M0.04%22.01B USD0.03%$32.61-1.47%
AdvisorShares Pure Cannabis ETFYOLO5.09M15.44%32.94M USD0.91%$2.765-1.20%
iShares Core S&P Total U.S. Stock Market ETFITOT2.39M0.00%98.16B USD0.03%$169.28-0.37%
Schwab U.S. Broad Market ETFSCHB1.09M0.00%45.4B USD0.03%$29.85-0.38%AdvisorShares Pure US Cannabis ETFMSOSAmplify Seymour Cannabis ETFCNBSSchwab U.S. Small-Cap ETFSCHAAdvisorShares Pure Cannabis ETFYOLOiShares Core S&P Total U.S. Stock Market ETFITOTSchwab U.S. Broad Market ETFSCHBAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
